Prix Galien Belgium 2014
By Poly Viniou on 22/09/20140Read moreSeptember 4th, 2014 The Belgian jury has awarded trastuzumab emtansine, KADCYLA T-DM1 (ROCHE) For additional information, please contact: Mr....
Prix Galien Switzerland 2014
By Poly Viniou on 21/09/2014Read moreJune 20th , 2014 The laureate this year was Fingolimod, GILENYA (NOVARTIS) For additional information, please contact: Dr Theo...
Prix Galien Greece 2015: Pro Bono Humanum Award
By Poly Viniou on 12/06/2014Read moreΑthens, June 12th , 2014 In Prix Galien Greece 2015, the award will be bestowed to Dr. Afxentios Kalangos,...
Prix Galien Greece 2015: Galien Scientific Research Award
By Poly Viniou on 12/06/2014Read moreΑthens, June 12th, 2014 As an institution par excellence that rewards research and innovation, Prix Galien could not exempt...
Prix Galien Greece 2015: Announcement for a New Awarding Category
By Poly Viniou on 20/05/2014Read moreAthens, May 2014 Prix Galien, being an institution with authority and simultaneously intense scientific, humanitarian, and social character, decided...
Prix Galien Greece 2015: New Awarding Category
By Poly Viniou on 18/02/2014Read moreAthens, February 2014 In the context of preparation of the 2nd ceremony of Prix Galien Greece, to be held...
Prix Galien Greece 2015 awards
By Poly Viniou on 17/02/2014Read moreAthens, February 2014 The date of conduct for the second awarding ceremony of the pharmaceutical awards Prix Galien Greece...
Prix Galien Canada 2013: the winners
By Poly Viniou on 13/01/2014Read moreToronto, Canada 2013 The laureates for Prix Galien Canada for 2013 are: Best Innovative Drug: Yervoy® (ipilimumab) / Bristol...
Awarding ceremonies program for Prix Galien in 2014 and 2015
By Poly Viniou on 13/01/2014Read morePlease find below, in chronological order, the program for the forthcoming ceremonies for the Prix Galien awards worldwide that...
International Prix Galien 2014
By Poly Viniou on 29/10/2013Read moreDecember 10th, 2014 The deadline for on-line submissions is May 15th, 2014 For additional information on submissions, please contact:...